MicroRNA sequencing detects miR-424-5p up-regulation in ovarian cancer stem cells

Cancer stem cells (CSCs) are cancer cells that possess the ability to undergo continuous proliferation and self-renewal. It has been postulated that CSCs are responsible for tumor growth, heterogeneity, invasion, metastasis, and recurrence. MicroRNAs (miRNAs), small non-coding RNAs of approximately...

Full description

Saved in:
Bibliographic Details
Published inGenes & genomics Vol. 37; no. 9; pp. 737 - 742
Main Authors Yun, J.H., KIST Gangneung Institute of Natural Products, Gangneung, Republic of Korea, Lim, J., Hallym University, Chuncheon, Republic of Korea, Ha, I.S., KIST Gangneung Institute of Natural Products, Gangneung, Republic of Korea, Shin, J.M., KIST Gangneung Institute of Natural Products, Gangneung, Republic of Korea, Kim, J.H., Sogang University, Seoul, Republic of Korea, Kim, J., Sogang University, Seoul, Republic of Korea, Nho, C.W., KIST Gangneung Institute of Natural Products, Gangneung, Republic of Korea, Cho, Y.S., Hallym University, Chuncheon, Republic of Korea
Format Journal Article
LanguageEnglish
Published Seoul The Genetics Society of Korea 01.09.2015
한국유전학회
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer stem cells (CSCs) are cancer cells that possess the ability to undergo continuous proliferation and self-renewal. It has been postulated that CSCs are responsible for tumor growth, heterogeneity, invasion, metastasis, and recurrence. MicroRNAs (miRNAs), small non-coding RNAs of approximately 22 nucleotides, are known to be involved in the maintenance of CSCs. To gain insight into the role of miRNAs in CSCs, we investigated the differential expression of miRNAs in ovarian CSCs compared to non-CSCs. Ovarian CSCs were isolated from the human ovarian cancer cell line SK-OV-3 using two ovarian CSC-specific surface markers, CD44 and CD117. The expression levels of miRNAs in CSCs and non-CSCs were estimated by miRNA sequencing. We detected four up-regulated miRNAs (miR-29a-5p, miR-34c-5p, miR-106a-5p, and miR-424-5p) in ovarian CSCs, and miR-424-5p was validated by real-time qPCR. MiR-424-5p target genes were predicted using several validated target databases and computational algorithms. Pathway analysis indicated that most miR-424-5p target genes are involved in cancer-related biological pathways. Overall, these results suggest that miR-424-5p is a potential regulator of CSCs that endows human ovarian tissue with tumorigenic potential and thus represents a potential therapeutic target for human ovarian cancer.
Bibliography:A50
http://dx.doi.org/10.1007/s13258-015-0299-9
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000317.2015.37.9.008
ISSN:1976-9571
2092-9293
DOI:10.1007/s13258-015-0299-9